Advertisement

Acta Diabetologica

, Volume 55, Issue 8, pp 821–826 | Cite as

Recent diabetes-related mortality trends in Romania

  • Sorin Ioacara
  • Elisabeta Sava
  • Olivia Georgescu
  • Anca Sirbu
  • Simona Fica
Original Article
  • 41 Downloads

Abstract

Aims

As there are no published articles on country-level diabetes-related mortality in Romania, we aimed to investigate this aspect for the 1998–2015 period.

Methods

Anonymized demographic and diabetes-related mortality data (underlying or first secondary cause of death) were retrospectively obtained from the National Institute of Statistics/Eurostat microdata. Age-standardized mortality rates (ASMR) and their annual percentage change (APC) were analysed.

Results

During 1998–2015, 4,567,899 persons died in Romania, among whom, diabetes was responsible for 168,854 cases. The ASMR for diabetes was 39.34 per 100,000 person-years (p-y) (95% CI 39.32–39.35). There was an increase in ASMR from 27.10 per 100,000 p-y (95% CI 27.01–27.19) in women and 30.88 per 100,000 p-y (95% CI 30.77–30.99) in men in 1998 to 35.42 per 100,000 p-y (95% CI 35.34–35.51) in women and 48.41 per 100,000 p-y (95% CI 48.29–48.52) in men, in 2015. The mean APC in women was 3.8% per year (95% CI 3.5–4.0, p < 0.001) during 1998–2010 and − 1.9% per year (95% CI − 2.7 to − 1.1, p < 0.001) during 2010–2015. The mean APC in men was 5.3% per year (95% CI 5.0–5.5, p < 0.001) during 1998–2010 and − 1.5% per year (95% CI − 2.2 to − 0.8, p < 0.001) during 2010–2015. Diabetes-related mortality rates increased with age, with men experiencing higher mortality rates than women for most age groups and calendar years.

Conclusions

Diabetes-related mortality rates increased significantly in Romania during 1998–2010, followed by a steady decline during 2010–2015.

Keywords

Mortality Life expectancy 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no competing interest.

Research involving human/animal participants

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

For this type of study formal consent is not required.

References

  1. 1.
    International Diabetes Federation (2017) IDF Diabetes Atlas, 8th edn. International Diabetes Federation, BrusselsGoogle Scholar
  2. 2.
    Tancredi M, Rosengren A, Svensson AM et al (2015) Excess mortality among persons with type 2 diabetes. N Engl J Med 373:1720–1732CrossRefPubMedGoogle Scholar
  3. 3.
    Wright AK, Kontopantelis E, Emsley R et al (2017) Life expectancy and cause-specific mortality in type 2 diabetes: a population based cohort study quantifying relationships in ethnic subgroups. Diabetes Care 40:338–345CrossRefPubMedGoogle Scholar
  4. 4.
    Cha SA, Yun JS, Lim TS et al (2016) Severe hypoglycemia and cardiovascular or all-cause mortality in patients with type 2 diabetes. Diabetes Metab J 40:202–210CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Sidney S, Quesenberry CPJR, Jaffe MG et al (2016) Recent trends in cardiovascular mortality in the United States and public health goals. JAMA Cardiol 1:594–599CrossRefPubMedGoogle Scholar
  6. 6.
    Malhão TA, Brito S, Pinheiro RS, Cabral S, Camargo TM, Coeli CM (2016) Sex differences in diabetes mellitus mortality trends in Brazil, 1980–2012. PLoS One 11:e0155996CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Mota M, Popa SG, Mota E et al (2016) Prevalence of diabetes mellitus and prediabetes in the adult Romanian population: PREDATORR study. J Diabetes 8:336–344CrossRefPubMedGoogle Scholar
  8. 8.
    Ioacara S, Guja C, Fica S, Ionescu-Tirgoviste C (2013) The dynamic of life expectancy in the last six decades in elder diabetes patients. Diabetes Res Clin Pract 99:217–222CrossRefPubMedGoogle Scholar
  9. 9.
    Ioacara S, Guja C, Ionescu-Tirgoviste C et al (2011) Improvements in life expectancy in adult type 2 diabetes patients in the last six decades. Diabetes Res Clin Pract 92:400–404CrossRefPubMedGoogle Scholar
  10. 10.
    Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJ, Lozano R, Inoue M et al. (2001) Age standardization of rates: a new WHO standard. Geneva World Health Organ. [Internet]. 9. http://www.who.int/entity/healthinfo/paper31.pdf?ua=1. Cited 8 Sept 2017
  11. 11.
    Evans JMM, Barnett KN, Ogston SA, Morris AD (2007) Increasing prevalence of type 2 diabetes in a Scottish population: effect of increasing incidence or decreasing. mortality? Diabetologia 50:729–732CrossRefPubMedGoogle Scholar
  12. 12.
    Charlton J, Latinovic R, Gulliford MC (2008) Explaining the decline in early mortality in men and women with type 2 diabetes: population-based cohort study. Diabete Care 31:1761–1766CrossRefGoogle Scholar
  13. 13.
    Faerch K, Carstensen B, Almdal TP, Jorgensen ME (2014) Improved survival among patients with complicated type 2 diabetes in Denmark: a prospective study (2002–2010). J Clin Endocrinol Metab 99:E642–E646CrossRefPubMedGoogle Scholar
  14. 14.
    Gregg EW, Li Y, Wang J et al (2014) Changes in diabetes-related complications in the United States, 1990–2010. N Engl J Med 370:1514–1523CrossRefPubMedGoogle Scholar
  15. 15.
    Redelings MD, Sorvillo F, Simon P (2006) A comparison of underlying cause and multiple causes of death. US Vital Statistics, 2000–2001. Epidemiology 17:100–103CrossRefPubMedGoogle Scholar
  16. 16.
    Popa S, Moţa M, Popa A et al (2016) Prevalence of overweight/obesity, abdominal obesity and metabolic syndrome and atypical cardiometabolic phenotypes in the adult Romanian population: PREDATORR study. J Endocrinol Invest 39:1045–1053CrossRefPubMedGoogle Scholar
  17. 17.
    Gæde P, Oellgaard J, Carstensen B et al (2016) Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial. Diabetologia 59:2298–2307CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Simmons RK, Griffin SJ, Lauritzen T, Sandbæk A (2017) Effect of screening for type 2 diabetes on risk of cardiovascular disease and mortality: a controlled trial among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009. Diabetologia 60:2192–2199CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Celebi O, Celebi S, Canbay A, Gokaslan S, Diker E (2014) Impaired heart rate recovery in patients with impaired glucose tolerance. Acta Endocrinol Bucharest 10:76–78CrossRefGoogle Scholar
  20. 20.
    National Report on the State of the Education System in Romania (2008). http://www.erisee.org/downloads/2013/2/r/National%20report%20on%20educational%20development%202008%20ENG.pdf. Accessed 2nd Oct 2017
  21. 21.
    Anderson RN, Miniño AM, Hoyert DL, Rosenberg HM (2001) Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates. Natl Vital Stat Rep 49:1–32PubMedGoogle Scholar
  22. 22.
    Jacobs E, Hoyer A, Brinks R, Kuss O, Rathmann W (2017) Burden of mortality attributable to diagnosed diabetes: a nationwide analysis based on claims data from 65 million people in Germany. Diabetes Care 40:1703–1709CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia S.r.l., part of Springer Nature 2018

Authors and Affiliations

  1. 1.“Carol Davila” University of Medicine and PharmacyBucharestRomania
  2. 2.“Elias” University Emergency HospitalBucharestRomania

Personalised recommendations